Automata expands its lab automation ambitions with $50M B round

The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. Automata, which got its start making a robotic arm for handling individual tasks, has now raised $50M to automate entire lab processes from start to finish.
When we last talked with Automata in 2019, the company had just raised a $7.4M A round and was focusing on developing and depl